Associate Professor John Ashton | University of Otago
WEBAshton, J. C., Bland, A. R., & Sammut, I. A. (2023). Treatment of lorlatinib induced hypercholesterolemia with PCSK9 inhibitors: A new solution to an emerging need in non-small cell lung cancer therapy.
Associate Professor John Ashton | University of Otago
WEBUniversity of Otago, Christchurch University of Otago, Wellington Toggle submenu Ako Ōtākou Learning and Teaching
John Ashton - Dr - University of Otago | LinkedIn
WEBDr. University of Otago. Jan 2005 - Present 19 years 1 month. Associate Professor in Pharmacology, lecturing in neuropharmacology. Research into lung cancer, neuropathic pain, neuroprotection,...
- Title: Associate Professor at the …
- Location: 81 followers
- Connections: 77
the cost of a life: Tackling 'offensive' stigma of disease - NZ …
WEBDr John Ashton, of Otago University has lung cancer. Photo / Supplied. In a five-part series, the Herald investigates controversies in cancer testing and treatment and reports …
John Ashton - The Conversation
WEBJohn Ashton’s profile on The Conversation ... Associate Professor, University of Otago Education. 2001 Massey, Biology Sign in to contact Article Feed Joined July 21, 2019 ...
Lung Cancer Patient Ambassador, Associate Professor John Ashton
WEBAt the age of 48, John Ashton was diagnosed with stage 4 lung cancer after a chronic cough did not respond to anti-asthma medication. He had never smoked. John lives on the Otago Peninsula with his wife and two sons, age 15 and 9 years of age and he hasn’t let lung cancer define him.
John Ashton (Lung Cancer Patient... - Lung Foundation NZ - Facebook
WEBJan 12, 2018 · John Ashton (Lung Cancer Patient Ambassador) has been promoted to the title of “Associate Professor”, by the University of Otago, effective the 1st February 2018. We are especially proud of John! His leadership and support helps ensure LFNZ has a very authentic and well informed patient voice..
Associate Professor John Ashton | Lung Foundation NZ
WEBMar 24, 2016 · John Ashton is a lecturer at the Department of Pharmacology and Toxicology, at the University of Otago. At the age of 48 he was diagnosed with stage 4 lung cancer after a chronic cough did not respond to anti-asthma medication.
Experimental power comes from powerful theories - Nature
WEBJul 3, 2013 · John C. Ashton is at the Department of Pharmacology & Toxicology, School of Medical Sciences, University of Otago, Dunedin 9140, New Zealand., John C. Ashton Authors
Mechanisms of suppression of cell growth by dual inhibition of …
WEBDec 11, 2019 · 2 Department of Pharmacology & Toxicology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand. [email protected]. PMID: 31827192 PMCID: PMC6906283